Key stats
About GBLX CURE ETF UNITS
Expense ratio
0.45%
Home page
Inception date
Nov 8, 2018
ISIN
AU0000028110
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region